Search Within

Benjamin Heath Durham

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (24)
  3. Correspondence (2)
  4. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (54)
  2. Center for Hematologic Malignancies (49)
  3. Department of Medicine (49)
  4. Hematologic Malignancies, Division of (49)
  5. GSK Faculty (45)
  6. Executive Committee, Center for Hematologic Malignancies (44)

More Groups

People
  1. Omar Abdel-Wahab (40)
  2. Eli Diamond (38)
  3. Ahmet Dogan (25)
  4. Kseniya Petrova-Drus (19)
  5. Raajit Rampal (17)
  6. Mariko Yabe (16)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (10)
  4. 2022 (4)
  5. 2020 (5)
  6. 2019 (6)

More Years

Publications
  1. Blood (16)
  2. Pediatric Blood and Cancer (7)
  3. Haematologica (3)
  4. British Journal of Haematology (2)
  5. Cancer Discovery (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Nature Publishing Group (8)
  3. Wiley Periodicals, Inc (7)
  4. American Association for Cancer Research (3)
  5. Ferrata Storti Foundation (3)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1
    Meeting Abstract

    Razanamahery, J.; Diamond, E.; Cohen-Aubart, F.; Karl-Heinz, P.; Charlotte, F.; Helias-Rodzewicz, Z.; Dogan, A.; Abdel-Wahab, O.; Durham, B.; Ozkaya, N.; more...
    Annals of the Rheumatic Diseases (2018)

    Fulltext@MSK | Save
  • Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
    Journal Article

    Taylor, J.; Pavlick, D.; Yoshimi, A.; Marcelus, C.; Chung, S. S.; Hechtman, J. F.; Benayed, R.; Cocco, E.; Durham, B. H.; Bitner, L.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis analysis of data from the histology-independent, phase 2, open-label VE-BASKET study
    Journal Article

    Diamond, E. L.; Subbiah, V.; Lockhart, A. C.; Blay, J. Y.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J.; Erinjeri, J. P.; Torrisi, J.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • The histopathology of Erdheim-Chester disease: A comprehensive review of a molecularly characterized cohort
    Journal Article

    Ozkaya, N.; Rosenblum, M. K.; Durham, B. H.; Pichardo, J. D.; Abdel-Wahab, O.; Hameed, M. R.; Busam, K. J.; Travis, W. D.; Diamond, E. L.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis
    Journal Article

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Lacouture, M. E.; Hajdenberg, J.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies
    Meeting Abstract

    Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
    Meeting Abstract

    Durham, B. H.; Getta, B.; Dietrich, S.; Taylor, J.; Won, H.; Bogenberger, J. M.; Scott, S. N.; Kim, E.; Chung, Y. R.; Chung, S. S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with BRAF V600-mutant and wild-type histiocytic disorders
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R. K.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
    Blood (2017)

    Fulltext@MSK | Save
  • Robust patient-derived xenografts (PDX) capture the disease fidelity of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
    Meeting Abstract

    Balasis, M. E.; Yoshimi, A.; Vedder, A.; Feldman, K.; Ma, Y.; Zhang, H.; Lee, S. C. W.; Letson, C.; Niyongere, S.; Lu, S. X.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save